Back
  1. Home
  2. Profile of Fabrice SUSIN (ULiège)
Profil

SUSIN Fabrice

Unilab > Unité de laboratoire - LRS Biomol

Laboratoire biologie moléculaire

See author's contact details
Main Referenced Co-authors
Vaira, Dolorès  (7)
Moutschen, Michel  (6)
Darcis, Gilles  (5)
Fombellida-Lopez, Céline  (5)
Hayette, Marie-Pierre  (4)
Main Referenced Keywords
Residual viremia (4); HIV reservoirs (3); Treatment intensification (3); Adults (1); Antiretroviral thérapy (1);
Main Referenced Disciplines
Immunology & infectious disease (6)
Laboratory medicine & medical technology (1)

Publications (total 7)

The most downloaded
115 downloads
KAMANGU, E., CHATTE, A., BOREUX, R., SUSIN, F., KALALA, R., Mwumbi, G. L., De Mol, P., Hayette, M.-P., & VAIRA, D. (March 2015). Comparison of an In-House Quantitative Real-Time PCR and COBAS ampliprep/Taqman Roche for determination of viral load for HIV type 1 non-b. Open Access Library Journal, 2 (e1402). doi:10.1186/1742-4690-9-S1-P146 https://hdl.handle.net/2268/189860

The most cited

7 citations (Scopus®)

Adawaye, C., Fokam, J., Kamangu, E., Alio, H. M., Chahad, A. M., SUSIN, F., Moussa, A. M., Bertin, T. H. Z., Tidjani, A., VAIRA, D., & Moutschen, M. (2017). Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N'Djamena, Chad: Findings from a cross-sectional study. BMC Research Notes, 10 (1). doi:10.1186/s13104-017-2893-1 https://hdl.handle.net/2268/234165

Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (11 September 2023). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. HIV Cure Symposium 2023, Gand, Belgium.

Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (21 February 2023). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. Conference on Retroviruses and Opportunistic Infection (CROI 2023), Seattle, United States.

Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (23 November 2022). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. Belgium Research on AIDS and HIV Consortium (BREACH 2022), Bruxelles, Belgium.

Fombellida-Lopez, C., Chaslain, A., SUSIN, F., VAIRA, D., Moutschen, M., & DARCIS, G. (September 2020). Obstacles à la guérison de l'infection par le VIH. Partie 1 : les réservoirs latents. Revue Médicale de Liège, 75 (9), 573-577.
Peer reviewed

Chaslain, A., Fombellida-Lopez, C., SUSIN, F., VAIRA, D., Moutschen, M., & Darcis, G. (September 2020). Obstacles à la guérison de l'infection par le VIH. Partie 2 : la réplication continue malgré le traitement. Revue Médicale de Liège, 75 (9), 582-587.
Peer reviewed

Adawaye, C., Fokam, J., Kamangu, E., Alio, H. M., Chahad, A. M., SUSIN, F., Moussa, A. M., Bertin, T. H. Z., Tidjani, A., VAIRA, D., & Moutschen, M. (2017). Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N'Djamena, Chad: Findings from a cross-sectional study. BMC Research Notes, 10 (1). doi:10.1186/s13104-017-2893-1
Peer Reviewed verified by ORBi

KAMANGU, E., CHATTE, A., BOREUX, R., SUSIN, F., KALALA, R., Mwumbi, G. L., De Mol, P., Hayette, M.-P., & VAIRA, D. (March 2015). Comparison of an In-House Quantitative Real-Time PCR and COBAS ampliprep/Taqman Roche for determination of viral load for HIV type 1 non-b. Open Access Library Journal, 2 (e1402). doi:10.1186/1742-4690-9-S1-P146
Peer reviewed

Contact ORBi